Learn More
R&D Systems™ Human NG2/MCSP Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 2585PG050
Description
The Recombinant Human NG2/MCSP/CSPG4 Protein is derived from NS0. The Recombinant Human NG2/MCSP/CSPG4 Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS. | |
69 kDa | |
50μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
1464 | |
NG2/MCSP | |
Mouse myeloma cell line,NS0-derived human NG2/MCSP protein Ser1583-Ser2224,with a C-terminal 6-His tag | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.